MARKETSNAP Daily Market Analysis: November 4, 2026
Welcome to MARKETSNAP's daily stock market analysis for November 4, 2026. Today's session delivered a striking twist: the market rallied on a Democratic sweep, yet the very names that have led the AI buildout fell sharply as state-level politics turned against the facilities those companies supply. The relief rally and the data-center selloff are not two separate stories—they are one story: a new policy map, priced in a single session.
Market Highlights
The shape of the day is the message. This was a broad rally led by the Dow, but not a uniform one. Leadership came from the old economy, not the AI complex—a signal that this was not a simple risk-on day but a rotation. Money did not merely return to the market; it moved from one set of policy assumptions to another.
– S&P 500: up approximately 1.6%
– Nasdaq: up slightly less
– Russell 2000: up roughly in line with the S&P
– Dow: up 3%
The outsized Dow gain is the tell. The Dow carries the heaviest weighting in old-economy cyclicals and healthcare, so its leadership confirms the rotation. Meanwhile, the VIX fell more than 20%, from above 19 to under 17—election uncertainty, gone in a day.
What the Market Is Pricing
The first read is gridlock: less movement on taxes, less movement on big spending, and investors bought that relief. But divided government is not no government. Regulation still moves. Subsidies still move. Permitting still moves—and permitting is decided largely at the state level. That is the part the market is already sorting: winners and losers by policy exposure, not by index membership.
Key Trends
Healthcare: The Clearest Winner
Healthcare was the standout sector, up more than 6%. HCA, Intuitive Surgical, and Stryker each rose around 9 to 10%. The logic here is relief more than new subsidy—a Democratic Congress reduces the odds of aggressive drug-pricing or insurance-rollback surprises landing quickly, and hospitals in particular read as beneficiaries. Moderna's 13% gain is the same trade in a purer form: vaccine-policy fear unwinding. This is a sector repricing its political risk, and doing it fast.
The Data-Center Selloff
The other side of today's tape is the most important part. Vertiv fell nearly 13%, Comfort Systems 15%, Quanta almost 12%, CoreWeave nearly 10%, and Oracle was lower as well. The most likely factor is that newly elected Democratic governors in key states are promising to pause or scrutinize data-center buildouts.
Yesterday, this analysis noted that the AI trade had changed hands to the suppliers and now needed quarter-by-quarter proof. Today the suppliers are the ones being repriced—but for a new reason. This is a permitting and local-approval story, not a demand story. The queue is the new bottleneck.
That reaction is rational. Slower permitting delays revenue recognition for the companies that build and equip these facilities, and it raises their cost of capital, because time is money when financing a buildout. What it does not do, by itself, is reduce AI demand. It changes the timeline and the political risk premium attached to that timeline. The market is repricing the path, not the destination—very different things, and confusing them is how investors sell good businesses at the wrong moment.
Oil and the Input-Cost Story
Crude fell more than 4%, below $90 a barrel, with Iran peace-talk hopes and a lower war premium the most likely factors. Energy was the worst sector at minus 4.3%, while consumer cyclical and consumer defensive both outperformed. A sustained drop in oil feeds straight through to inflation and to margins—which is why this is an input-cost story for the whole market, not just a bad day for producers. Whether the war premium is gone for good remains the open question.
Company-Specific Reversals
CVS fell 12.5% after announcing it will split retail pharmacy from insurance and pharmacy-benefit operations by early 2028—reversing the logic of the Aetna acquisition. The market is treating that as an admission the combination never worked. The fair question is not whether the split is bold, but whether the sum of the parts is genuinely worth more than the whole was. That valuation argument is now the only one that matters here.
The mega-caps tell the same split in miniature. Nvidia fell more than 3% while the broad market rose—the permitting fear reaches the biggest name in the complex. Amazon rose 6%, read as a beneficiary of cheaper oil and gridlock given its consumer and cloud exposure. Same session, same election, opposite reactions. That dispersion is the story: this was not a market deciding whether to be bullish, but a market deciding which businesses face a different policy future than they did yesterday morning.
3M was the cleanest single-stock story of the day. It settled the PFAS personal-injury litigation—a $7.4 billion agreement covering up to 120,000 plaintiffs—and authorized a $6 billion buyback. Shares rose almost 10%. The market is pricing a cap on the legal tail, a genuine change in the risk profile rather than a mood swing. Whether the buyback is the best use of that cash is a separate question worth asking, but the overhang shrinking is real.
Datadog is the opposite kind of move. It beat on earnings, grew revenue 35%, and still fell more than 14% because it guided fourth-quarter revenue roughly flat versus the third. For a premium-multiple software name, a flat guide is enough to reset expectations on its own. The real question is whether this is a one-quarter pause in deal timing or the first sign that cloud-software growth is decelerating. Those two answers imply very different valuations, and one quarter won't settle it.
Separating the Durable From the Noise
– Durable: local approval risk, crude's pass-through to inflation and margins, and settlements that cap legal tails—these change assumptions, not just prices.
– Unproven: the one-day volatility collapse and the broadest relief moves, which can fade as fast as they arrived.
The test is whether policy actually follows the promises—governors' actions, state permitting decisions, federal rulemaking. Until then, treat the sector rotation as a hypothesis, not a conclusion.
This is the investor's real problem today. A regime change means the assumptions inside your own thesis may need rewriting—and most people won't remember what they believed before this week. That is precisely what the MARKETSNAP Investment Journal at marketsnap.com is designed for: a long-term home for every Investment Case you build, the place you return to see what you believed, what changed, and whether the case still holds. Not to trade the headline—to check your own reasoning against it.
Looking Ahead
Friday brings October nonfarm payrolls and the unemployment rate—the first big macro read after the election, and one the Fed will be watching closely. On Thursday, Cigna and Cardinal Health report, extending the healthcare read-through. Keep an eye on whether the data-center names stabilize or extend the selloff as the first local rulings arrive.
Conclusion
The election rewrote the rules investors are pricing. The first trade was to sell the buildout and buy healthcare. What lasts depends on whether campaign talk becomes governing reality. This concludes today's market analysis. This content is for educational purposes and is not financial advice—always do your own research.
